Sara Abdalrazzaq M. Noraldeen

2 ta ish

Department of Oncology and Metabolism, University of Tabuk, Tabuk, Saudi Arabia

1. Involving stemness factors to improve CAR T-cell-based cancer immunotherapy

   Sara Abdalrazzaq M. Noraldeen, Irodakhon Rasulova, R. Lalitha +8

   Sharh maqolaCAR-T cell therapy researchMedical Oncology20231 iqtibos

   ABIABI:AkademIndex/openalex/2023.review-article.000057

2. Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment

   Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen +7

   MaqolaAngiogenesis and VEGF in CancerMicrovascular Research20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.003439